A small South Korean study has found that Acceptance and Commitment Therapy (ACT) can reduce depressive symptoms and is accompanied by specific changes in brain activity tied to emotional regulation. The research tracked neural shifts as adults with major depressive disorder completed an eight‑week ACT program.
Major depressive disorder remains widespread, with many patients not achieving full recovery through antidepressants or traditional talk therapies alone. In response, clinicians are testing alternative approaches such as ACT, which focuses on altering how people relate to their thoughts rather than trying to change the thoughts themselves.
ACT centres on psychological flexibility, encouraging patients to live meaningful lives even in the face of internal distress. A key idea is cognitive fusion, where individuals treat their internal thoughts as literal truths. For example, the thought “I am a burden” might be accepted as fact, intensifying distress and avoidance behaviors.
Therapists use ACT to promote cognitive defusion, helping patients detach from rigid thought patterns. While trials have shown the therapy can ease depressive symptoms, there has been less clarity about the biological changes it generates in the brain, with brain imaging research on ACT remaining comparatively scarce.
The study, conducted in South Korea, involved researchers from Kyungpook National University who sought to observe brain activity before and after a specialised ACT programme. The team included Sang Won Lee, Seungho Kim, Hyunsoo Kim, Yongmin Chang, and Seung Jae Lee.
Forty-two adults diagnosed with major depressive disorder were recruited, with half randomly assigned to eight weeks of group‑based ACT and the other half placed on a waitlist as a baseline comparison. The researchers acknowledged the relatively small sample size limits generalisability and statistical power.
All participants underwent clinical evaluations and functional magnetic resonance imaging (fMRI) before the eight‑week period began. During scanning, they performed a task designed to provoke cognitive fusion by asking them to mentally couple their thoughts with real‑world consequences.
Participants named two people they felt close to and two neutral acquaintances. In the scanner, they read negative statements involving these individuals and rated the emotional intensity and their reaction speed. The task compelled the brain to process distressing, imagined scenarios as if they were real events.
After eight weeks, the therapy group showed notable psychological improvements: reduced depressive symptom severity and lower levels of cognitive fusion and experiential avoidance compared with their baseline scores. The waitlist group did not show these changes.
In the imaging data, practitioners observed increased activation in the medial prefrontal cortex and the anterior cingulate cortex among those who received ACT. These regions are central to emotional regulation and attention, and are often less active in people with depression during emotional tasks.
Higher activity in these brain areas correlated with fewer depressive symptoms and less obsessive thinking. The therapy group also demonstrated faster responses during the scanner task, aligning with the observed neural changes in emotion‑regulating regions.
Beyond regional activity, the researchers found strengthened connectivity within the brain’s default mode network, specifically between the medial prefrontal cortex and the posterior cingulate cortex. Stronger communication between these areas was linked to lower rumination scores, suggesting a neural mechanism by which ACT may disrupt repetitive negative thinking.
However, the study has several caveats. The comparison to a waitlist, rather than an active treatment control, means it cannot determine whether the neural changes are unique to ACT or could arise from structured psychological support in general. Additionally, most participants continued their prescribed antidepressants during the trial, making it difficult to isolate the effects of the therapy itself.
Measurement limitations also apply: some questionnaires used to assess psychological flexibility and experiential avoidance overlap with general distress, complicating interpretations of true flexibility gains. Importantly, outcomes were only measured immediately after the eight‑week programme, with no data on the durability of brain changes over time.
The study is titled Neural correlates of acceptance and commitment therapy in major depressive disorder: a task-based fMRI study and was authored by Sang Won Lee, Seungho Kim, Hyunsoo Kim, Yongmin Chang, and Seung Jae Lee.
